These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19132256)

  • 1. On the significance of marginally low von Willebrand factor.
    Onundarson PT; Gudmundsdottir BR; Marder VJ
    Thromb Haemost; 2008 Dec; 100(6):1213-4. PubMed ID: 19132256
    [No Abstract]   [Full Text] [Related]  

  • 2. Why make a diagnosis?
    Lipton R
    Blood; 2007 May; 109(9):4106; author reply 4106. PubMed ID: 17449804
    [No Abstract]   [Full Text] [Related]  

  • 3. [Von Willebrand disease: a common and unrecognized bleeding disorder].
    Boehlen F; Robert-Ebadi H; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic implications of a co-existent haemorrhagic and thrombotic genotype.
    Thachil J; Martlew V
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):232-4. PubMed ID: 22343681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined clotting factor deficiencies: experience at a single hemophilia treatment center.
    O'Brien SH; Ritchey AK; Ragni MV
    Haemophilia; 2007 Jan; 13(1):26-9. PubMed ID: 17212721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a self-administrated pediatric bleeding questionnaire measuring bleeding severity in children.
    Boelaars MF; Peters M; Fijnvandraat K
    Thromb Haemost; 2012 Nov; 108(5):1006-7. PubMed ID: 23014633
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Method of determining von Willebrand factor activity].
    Papaian LP
    Lab Delo; 1982; (5):275-8. PubMed ID: 6178881
    [No Abstract]   [Full Text] [Related]  

  • 11. The bleeding tendency in patients with low von Willebrand factor and type 1 phenotype is greater in the presence of impaired collagen-induced platelet aggregation.
    Weiss HJ
    J Thromb Haemost; 2004 Jan; 2(1):198-9. PubMed ID: 14717988
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosing von Willebrand disease.
    Crownover BK; Sleuwen L; Carls C; Ketterman B
    Am Fam Physician; 2010 Jun; 81(12):1415-8. PubMed ID: 20540477
    [No Abstract]   [Full Text] [Related]  

  • 13. Type 2B von Willebrand's disease and angiodysplasia.
    Hertzberg MS; Facey DA; Favaloro EJ; Koutts J
    Thromb Haemost; 1999 Nov; 82(5):1557-8. PubMed ID: 10595657
    [No Abstract]   [Full Text] [Related]  

  • 14. von Willebrand factor multimers: their demonstration and significance.
    McLellan DS; Webb C
    Med Lab Sci; 1988 Oct; 45(4):358-69. PubMed ID: 3077427
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet von Willebrand factor in inherited and acquired bleeding disorders.
    Mannucci PM
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2428-32. PubMed ID: 7708659
    [No Abstract]   [Full Text] [Related]  

  • 16. Von Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval.
    Moayeri SE; Coutre SE; Ramirez EJ; Westphal LM
    Am J Obstet Gynecol; 2007 Apr; 196(4):e10-1. PubMed ID: 17403383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses to von Willebrand factor study.
    Dodds WJ
    J Am Vet Med Assoc; 1996 Dec; 209(11):1838-9; author reply 1839-40. PubMed ID: 8944791
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2B von Willebrand disease in seven individuals from three different families: phenotypic and genotypic characterization.
    Szántó T; Schlammadinger A; Salles I; Pareyn I; Vauterin S; Hársfalvi J; Vanden Bulcke AM; Deckmyn H; Vanhoorelbeke K
    Thromb Haemost; 2007 Jul; 98(1):251-4. PubMed ID: 17598021
    [No Abstract]   [Full Text] [Related]  

  • 20. Heyde's syndrome without a decrease in large von Willebrand factor multimers: a case of intestinal bleedings reversed by valve replacement in a patient with aortic stenosis.
    Undas A; Windyga J; Bykowska K; Dimitrow PP; Stepien E; Sadowski J
    Thromb Haemost; 2009 Apr; 101(4):773-4. PubMed ID: 19350125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.